Advanced Renal Cell Carcinoma
Conditions
Brief summary
Phase 1: The main goal of phase 1 will check and count for how many people have side-effects or serious side-effects from the medicine, if anyone must stop taking it because of these side-effects , and if any side-effects cause death., Phase 2: The main goal of phase 2 will be to check and count how many people's kidney cancer gets much smaller or completely goes away with the treatment (OR (Objective Response) (confirmed CR (complete response) or PR (partial response)).
Detailed description
Count how many people have side-effects or serious side-effects from the medicines, including those who stop treatment or die because of them (safety)., See how long people live without the cancer getting worse, and how long the cancer stays smaller or goes away (progression delay (PFS, Progression-Free Survival and duration (DOR, Duration of Response).
Interventions
Sponsors
Bristol-Myers Squibb Services Unlimited Company
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Phase 1: The main goal of phase 1 will check and count for how many people have side-effects or serious side-effects from the medicine, if anyone must stop taking it because of these side-effects , and if any side-effects cause death., Phase 2: The main goal of phase 2 will be to check and count how many people's kidney cancer gets much smaller or completely goes away with the treatment (OR (Objective Response) (confirmed CR (complete response) or PR (partial response)). | — |
Secondary
| Measure | Time frame |
|---|---|
| Count how many people have side-effects or serious side-effects from the medicines, including those who stop treatment or die because of them (safety)., See how long people live without the cancer getting worse, and how long the cancer stays smaller or goes away (progression delay (PFS, Progression-Free Survival and duration (DOR, Duration of Response). | — |
Outcome results
None listed